KCM
AGIO icon

Kornitzer Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Kornitzer Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-83,300
Closed -$3.82M – 422
2014
Q2 		$3.82M Sell
83,300
-16,000
-16% -$652K 0.04% 276
2014
Q1 		$3.89M Sell
99,300
-40,600
-29% -$1.36M 0.04% 283
2013
Q4 		$3.35M Buy
139,900
+30,700
+28% +$700K 0.04% 296
2013
Q3 		$3.05M Buy
+109,200
New +$3.01M 0.04% 290

Other funds holding AGIO

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TRV
Third Rock Ventures Boston, Massachusetts $1.07B AUM 170.23% 1-Year Est. Return
FV2GP
Flagship Ventures 2007 General Partner Cambridge, Massachusetts $107M AUM
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Kornitzer Capital Management's AGIO Position: Q3 2014 in Review

Kornitzer Capital Management sold out of Agios Pharmaceuticals (AGIO) in Q3 2014, closing a stake of 83,300 shares — an estimated $3.82M sold.

Kornitzer Capital Management first reported a position in AGIO in Q3 2013 and held it in 4 quarters. The position peaked at $3.89M in Q1 2014. 120 funds tracked by Wall St. Rank hold AGIO as of Q3 2014.

  • Kornitzer Capital Management reported no remaining Agios Pharmaceuticals position as of Q3 2014 after selling out during the quarter.
  • Kornitzer Capital Management sold 83,300 Agios Pharmaceuticals shares in Q3 2014, an estimated $3.82M.
  • Kornitzer Capital Management first reported a position in Agios Pharmaceuticals in Q3 2013 and held it in 4 quarters.
  • Kornitzer Capital Management's Agios Pharmaceuticals position peaked at $3.89M in Q1 2014.
  • 120 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2014.

Based on Kornitzer Capital Management's 13F filing for Q3 2014, filed 29 Oct 2014.